[NF Energyvingsrporation of America 21 Jia Bei Si Dong Road Tie Xi Qu Shenyang, 110021 Filed via EDGAR 100 F. Street, NE Attention: Mr. Johnsh, Branch Chief NF Energyvingsrporation of America Form 10-K for the year ended December 31, 2008 File No. 0-50155 Dear Sirs:]
[Canadian Solar Reports Third Quarter 2009 Results Q309 Highlights 87% increase in net revenues to $213.1 million, compared to Q209 net revenues of $114.2 million. 113% increase in shipments of 102.6 MW, compared to Q209 shipments of 48.2 MW, setting a new quarterly shipping record. Gross margin of 16.3%, compared to Q209 gross margin of 20.2% and] [CANADIAN SOLAR INC. Form 6-K TABLE OF CONTENTS EX-99.1 - Press Release CANADIAN SOLAR INC. Shawn (Xiaohua) Qu Chairman, President and]
[Canadian Solar Reports Third Quarter 2009 Results Q309 Highlights 87% increase in net revenues to $213.1 million, compared to Q209 net revenues of $114.2 million. 113% increase in shipments of 102.6 MW, compared to Q209 shipments of 48.2 MW, setting a new quarterly shipping record. Gross margin of 16.3%, compared to Q209 gross margin of 20.2% and] [CANADIAN SOLAR INC. Form 6-K TABLE OF CONTENTS EX-99.1 - Press Release CANADIAN SOLAR INC. Shawn (Xiaohua) Qu Chairman, President and]
[Sinovac Reports Unaudited Third Quarter 2009 Financial Results - Conference call scheduled Monday, November 16, 2009 at 9:00 a.m. ET - BEIJING, Nov. 15 /PRNewswire-Asia/ Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2009. Financial Highlights · Sales for the] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
[Sinovac Reports Unaudited Third Quarter 2009 Financial Results - Conference call scheduled Monday, November 16, 2009 at 9:00 a.m. ET - BEIJING, Nov. 15 /PRNewswire-Asia/ Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2009. Financial Highlights · Sales for the] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
[Law Debenture Corporate Services Inc. Copies to: st David T. Zhang, Esq. Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement. o ý o o o o CALCULATION OF REGISTRATION FEE] [[Letterhead of Rhudd & Associates] November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the Prospectus) contained] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road Haidian District, Beijing 100085 Peoples Republic of China Ladies and Gentlemen: Company Securities Registration Statement We have acted as special U.S. counsel to Sinovac Biotech Ltd., a limited liability corporation incorporated in Antigua, West Indies (the The facts, as we understand them, and upon which with your permission we] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the Prospectus) contained in the Registration Statement. We] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Vancouver, Canada, November 18, 2009 Chartered Accountants]
[Law Debenture Corporate Services Inc. Copies to: st David T. Zhang, Esq. Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement. o ý o o o o CALCULATION OF REGISTRATION FEE] [[Letterhead of Rhudd & Associates] November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the Prospectus) contained] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road Haidian District, Beijing 100085 Peoples Republic of China Ladies and Gentlemen: Company Securities Registration Statement We have acted as special U.S. counsel to Sinovac Biotech Ltd., a limited liability corporation incorporated in Antigua, West Indies (the The facts, as we understand them, and upon which with your permission we] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the Prospectus) contained in the Registration Statement. We] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Vancouver, Canada, November 18, 2009 Chartered Accountants]
[SINOVAC BIOTECH LTD. CONSOLIDATED FINANCIAL STATEMENTS (Expressed in U.S. Dollars) (Unaudited) September 30 , 2009 Index Consolidated Balance Sheets Consolidated Statement of Changes in Stockholders Equity Consolidated Statements of Income and Comprehensive Income Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements SINOVAC BIOTECH LTD. Consolidated Balance Sheets (Unaudited) (Expressed in U.S. Dollars) September 30, December 31, 2009 2008] [1 -32371 SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o Submission of Financial Statements We are including in this Current Report on Form 6-K our unaudited consolidated financial statements for the three months and nine months ended September 30, 2008 and 2009 and as of]
